Biologics License Application acceptance supported by results from the Phase 3 Vivacity-MG3 study Results demonstrate sustained disease control over 24 weeks in a broad ...

CAR-T cell therapy, a marvel of bioengineering, takes a patient’s own immune cells and reprograms them to attack cells causing Lupus. First approved for treating leukemia in 2017, CAR-T cell therapy ...

Inaticabtagene autoleucel is under clinical development by Juventas Cell Therapy and currently in Phase I for Acquired (Autoimmune) Hemolytic Anemia ... Inaticabtagene Autoleucel is indicated for the ...

AiCuris Anti-infective Cures (AiCuris) is a clinical stage biopharmaceutical company that develops novel therapeutic drugs for treating severe infectious diseases in immunocompromised patients. The ...

Peter Chin-Hong, an infectious disease specialist at UC San Francisco, said people should be on the lookout for the “Big Four”: three respiratory viruses currently moving through the U.S ...

By that night, Republicans had shot down the budget proposal — and with it any hope that Musk and Vivek Ramaswamy's Department of Government Efficiency (abbreviated, annoyingly, as DOGE ...

Some foods are helpful to incorporate, and certain diets should be considered when creating a treatment ... Celiac disease is a health condition characterized by an autoimmune response to the ...

It's conference champ versus conference champ for the 2024 Cure Bowl as Conference USA champion ... Well, these aren't just any ol' conference champs, they both decimated their opponents in ...

These disorders may cause a range of symptoms. However, some autoimmune conditions may not cause any symptoms in the ... of something that requires urgent treatment. Doctors always check for ...

Back to Healio WASHINGTON — A phase 1/2 study of CD19 chimeric antigen receptor T-cell therapy in lupus and other autoimmune diseases demonstrated ... to Schett, the treatment yielded “very ...